Michael Pellini

Foundation Medicine
United States of America


Michael Pellini, M.D. joined Foundation Medicine as President and Chief Executive Officer in May 2011 and transitioned to Chairman in February 2017.  As a physician with more than 20 years of operating experience with companies at the forefront of the clinical diagnostics and laboratory industries, Dr. Pellini brings a breadth of understanding in personalized medicine, with a particular interest and focus in oncology.  He currently serves as a member of the Board of Directors for Mass BIO, Tango Therapeutics, Singular Genomics, and the Personalized Medicine Coalition, in addition to his Board Chair position with Foundation Medicine.  Dr. Pellini is a member of the President’s Leadership Council for the Sydney Kimmel Medical School at Thomas Jefferson University.